**3.3 Proteomics**

As proteins directly carry out cellular functions and disease processes, protein biomarkers have great potential for T1D prediction and monitoring treatment outcomes. The proteomic analysis allows us to discover and quantify these proteins on a large scale. Proteomic techniques can be divided into two main types: mass spectrometry-based and array-based (**Table 3**) [54].
